科研入门必备！《间充质干细胞：培养与三系诱导全解》免费领取

Core Viewpoint - OriCell, a subsidiary of Saiye, focuses on cell biology and stem cell technology services, emphasizing the importance of mesenchymal stem cells (MSC) in regenerative medicine and their growing application in clinical trials [2][10]. Group 1: MSC Research and Development - MSCs have unique differentiation potential and immune regulation capabilities, making them a key focus in regenerative medicine [2]. - The National Medical Products Administration (NMPA) has approved nearly 200 clinical trial applications for stem cell products, with the first MSC therapy, "Aimi Maitosai Injection," set to launch in early 2025 for treating hormone-refractory acute graft-versus-host disease [2]. - The application boundaries of MSCs are expanding, serving as a crucial bridge between basic research and clinical translation [2]. Group 2: Research Support and Resources - OriCell has compiled a research guide titled "Mesenchymal Stem Cells: Cultivation and Tri-lineage Induction," aimed at both newcomers and experienced research teams to provide practical technical support [3]. - The guide offers a systematic framework of MSC knowledge, detailing definitions, characteristics from different sources, and biological functions to help establish foundational understanding [5]. - It includes standardized operational processes, breaking down key procedures such as cell passage digestion time, cryopreservation points, and recovery plating density, along with tri-lineage induction steps and identification methods [5]. Group 3: Practical Solutions and Optimization - The guide provides practical solutions to common experimental challenges, analyzing factors like serum quality and culture temperature, and offering validated optimization strategies to avoid typical pitfalls in experiments [5]. - OriCell aims to enhance the confidence in MSC cultivation and induction processes, supporting researchers in overcoming experimental difficulties [7].